Wayne Tam

Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis.

Accumulation of miR-155 and BIC RNA in human B cell lymphomas.

Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice.

miR-155/BIC as an oncogenic microRNA.

Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.

Lack of A563G (I188V) missense mutation in RIZ/ PRDM2 in human diffuse large B-cell lymphomas.

Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast.

A mammalian microRNA expression atlas based on small RNA library sequencing.

MicroRNAs in tumorigenesis: a primer.

Significance of PRDM1beta expression as a prognostic marker in diffuse large B-cell lymphomas.

Primary esophageal large T-cell lymphoma mimicking esophageal carcinoma: a case report and literature review.

MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.

The emergent role of microRNAs in molecular diagnostics of cancer.

Tumorigenic activity and therapeutic inhibition of Rheb GTPase.

Micro-classifying diffuse large B-cell lymphomas.

Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma.

Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival.

Histiocytic sarcoma with interdigitating dendritic cell differentiation: a case report with fine needle aspiration cytology and review of literature.

Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone.

MicroRNAs of the immune system: roles in inflammation and cancer.

Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.

Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.

Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement.

Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice.

A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.

The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma.

B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen.

Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma are biclonal lymphomas: a report of two cases.

Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.

Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.

Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047.

Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma.

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy.

The genetics of interdigitating dendritic cell sarcoma share some changes with Langerhans cell histiocytosis in select cases.

Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance.

Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.

Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas.

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients.

Cryptococcosis in bone marrow following treatment for Hodgkin lymphoma.

Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.

Massive splenic hamartoma with bizarre stromal cells.

The tumor virus landscape of AIDS-related lymphomas.

Epigenomic evolution in diffuse large B-cell lymphomas.

The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.

Primary Cutaneous Follicle Center Lymphoma Associated With an Extracutaneous Dissemination: A Cytogenetic Finding of Potential Prognostic Value.

Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma.

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.